News

Pharmabiz13h
Merck announces 2025 Merck Young Scientist Award
Our Bureau, Bengaluru Wednesday, July 2, 2025, 16:15 Hrs [IST] Merck is back with its fourth edition of the Merck Young Scientist ...
Pharmabiz11h
Gain Therapeutics completes enrollment in phase 1b study to evaluate GT-02287 in Parkinson’s disease with or without a GBA1 mutation
Bethesda, Maryland Wednesday, July 2, 2025, 18:00 Hrs [IST] ...
Pharmabiz14h
AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country
AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country: Our Bureau, Bengaluru Wednesday, July 2, 2025, 15:15 Hrs [IST] AstraZeneca Pharma Indi ...
Pharmabiz12h
Parexel to strengthen regulatory, medical and AI expertise; appoints Lola Fashoyin-Aje and Tala Fakhouri to its consulting team
Parexel to strengthen regulatory, medical and AI expertise; appoints Lola Fashoyin-Aje and Tala Fakhouri to its consulting team: Our Bureau, Bengaluru Wednesday, July 2, 2025, 16: ...
Pharmabiz18h
Karnataka govt informs DCGI to probe into 'unfair clinical trials' at HCG
Karnataka govt informs DCGI to probe into 'unfair clinical trials' at HCG: Our Bureau, Bengaluru Wednesday, July 2, 2025, 11:10 Hrs [IST] Karnataka government has written to the D ...
Pharmabiz12h
University of Salford, CSIR-IGIB and ORDI host glaucoma awareness and advocacy workshop
University of Salford, CSIR-IGIB and ORDI host glaucoma awareness and advocacy workshop: Our Bureau, Bengaluru Wednesday, July 2, 2025, 17:15 Hrs [IST] The University of Salford ( ...
Pharmabiz13h
Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine
Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine: Cambridge, Massachusetts Wednesday, July 2, 2025, 16:00 Hrs [IST] Moderna, Inc ...
Pharmabiz17h
Lupin receives US FDA approval for loteprednol etabonate ophthalmic gel
Lupin receives US FDA approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Wednesday, July 2, 2025, 11:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...
Pharmabiz13h
Nymi and Caliber Technologies ink pact to enable passwordless authentication in pharma manufacturing
Nymi and Caliber Technologies ink pact to enable passwordless authentication in pharma manufacturing: Our Bureau, Bengaluru Wednesday, July 2, 2025, 15:30 Hrs [IST] Nymi, an Innom ...
Pharmabiz15h
Repronovo announces first participant included in US phase 2 trial of RPN-001 to treat MALE INFERTILITY
Repronovo announces first participant included in US phase 2 trial of RPN-001 to treat MALE INFERTILITY: Lausanne, Switzerland Wednesday, July 2, 2025, 14:00 Hrs [IST] ReproNovo, ...
Pharmabiz14h
US FDA clears Iksuda Therapeutics’ IND application for IKS014
US FDA clears Iksuda Therapeutics’ IND application for IKS014: New Castle, England Wednesday, July 2, 2025, 15:00 Hrs [IST] Iksuda Therapeutics, a clinical stage and UK-based bi ...
Pharmabiz16h
NIH study shows breast cancer risk in younger women may be influenced by hormone therapy
NIH study shows breast cancer risk in younger women may be influenced by hormone therapy: Bethesda, Maryland Wednesday, July 2, 2025, 13:00 Hrs [IST] Scientists at the National In ...